Principal Investigator Kevin Esvelt
Principal Investigator Polina Anikeeva
Yoel Fink Professor of Materials Science and Electrical Engineering, MIT CEO, AFFOA
Polina Anikeeva Associate Professor, Materials Science & Engineering, Brain & Cognitive Sciences
In the last decade, the science of cell therapy and regenerative medicine has made remarkable progress. Work in this area has also resulted in numerous engineering successes, enabling sophisticated tools that open the door to new approaches for discovery and development of therapeutics. Particularly noteworthy is the recent progress in cell and molecular biology, including in stem cell research and gene editing. In this webinar, we will hear about new tools and the new directions they make possible as well as how each is being commercialized.
How can small molecules be identified that evoke cell or tissue regeneration by design? How can we engineer cells and tissue-growth in situ with a structure suitable for implantation? How can we physically gain access to the interior of cells for both discovery and engineering purposes? And how can the immune system be mapped with single-cell biology to accelerate discovery?
Principal Investigator Laura A Rose
After many years leading the global technology practice for asset-heavy industries, MIT alumnus Tor Jakob Ramsøy launched Arundo two and a half years ago to provide large-scale analytics and increased asset utilization.
Donna Rhodes